|
|
Research Collaboration Agreement to screen thousands of known molecules against host targets building upon the Fenretinide (ISLA-101) discovery sourced from these laboratories that the Company has licensed for use against Flaviviruses
|
|
|
Research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy. The small molecule libraries for Drug Discovery (GRIDD) Compounds Australia facility, using highly sensitive assays.
|
|
|
Research collaboration agreement signed with Australia’s largest drug library containing approximately four and a half thousand molecules that can be searched for drug re-purposing and pipeline development
|
|
|
Cooperative Research and Development Agreement (CRADA) with the US Army in preparation for its Phase II clinical study for ISLA-101
|
|
|
Supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants
|
|
|
Right to reference National Cancer Institute IND for Isla101
|
.png){kind=logo}
